Publication | Closed Access

Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells

NanoparticlesNanomedicineCell-based Drug DeliveryPluronic F127EngineeringTherapeutic NanomaterialsPharmaceutical NanotechnologyNano-drug DeliveryBiomedical EngineeringMatrix BiologyCancer Stem-like CellsTargeted Co-delivery